Michael Krel
InvestorPartner, Industrial Biotech Strategy at Sofinnova Partners · Board director at Werewool
Paris, France
Writes $100K – $5M checks · typically $1.5M
About
Partner in Sofinnova's Industrial Biotech Strategy since 2013, focused on early-stage deals in Europe and North America across chemicals, materials, agriculture, food, feed, and synthetic biology. Previously spent six years in industrial biotech startups in business development and worked in strategy consulting; also served two years as CEO of portfolio company EnobraQ.
Contact· self-published, not guessed
Invests in
AgTechBiotechClimate TechFoodTechNew Materials
Board director at Werewool
Intro paths
→
In turn, Michael can intro founders to Werewool's investors below.
Werewool's investors · 2
Co-founders at Werewool
VG
Valentina GomezExecutive Officer, Director
TS
Theanne SchirosExecutive Officer
CL
Chui-lian LeeExecutive Officer, Director
CL
Chui-Lian LeeFounder
Experience
- VerleyBoard Membercurrent2023 — present
- MicrophytBoard Membercurrent2022 — present
- MeiogenixBoard Membercurrent2021 — presentVille de Paris, Île-de-France, France
- ELICIT PLANTBoard Membercurrent2021 — presentVilhonneur, Nouvelle-Aquitaine, France
- Sofinnova PartnersPartnercurrent2020 — presentParis
- Sofinnova PartnersPrincipal2017 — 2020Paris Area, France
- Sofinnova Partnerssenior associate2013 — 2017Paris
- EnginzymeBoard Membercurrent2020 — present
- AFYRENBoard membercurrent2019 — present
- WerewoolBoard Member2023 — 2025Brooklyn, New York, États-Unis
- Comet BioBoard observer2016 — 2023
- EnobraQMember of the Board2017 — 2020Ramonville-Saint-Agne, Midi-Pyrénées, France
- EnobraQCEO2015 — 2017Ramonville Saint Agne
- DeinoveVP Business Development2010 — 2013
- Metabolic explorerbusiness development manager2007 — 2010
- Arendi Consultingconsultant2005 — 2007
- ICNS CNRSdoctorant/ cadre de laboratoire2002 — 2005
Skills & more
Business Development4Biotechnology3Technology Transfer1BiofuelsR&D5LifesciencesBusiness Strategy4Chemistry1Innovation Management2Pharmaceutical IndustryOrganic ChemistryBiochemistry2
+12 more
BiomassBiopharmaceuticalsProduct DevelopmentCommercializationConception de produitChimieGestion de l'innovationBiochimieStratégieSciences de la vieBiotechnologieTransfert technologiqueLanguages english
From Michael's professional profile.
Investments
Board seats
AfyrenComet BioElicit PlantEnginzymeEnobraQMeiogenix
Per the firm's website.
Colleagues at Sofinnova Partners
Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alex Leech
Partner, Biovelocita Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andrew M. Weiss
Venture Partner at Sofinnova Partners
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners
Network3
Anne Osdoit
Partner, MD Start Strategy at Sofinnova Partners
Anta Gkelou
Partner, Capital Strategy at Sofinnova Partners
Gonzague Issenmann
Investor at Sofinnova Partners
Investors connected to Michael in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Michael Krel?
- Partner in Sofinnova's Industrial Biotech Strategy since 2013, focused on early-stage deals in Europe and North America across chemicals, materials, agriculture, food, feed, and synthetic biology. Previously spent six years in industrial biotech startups in business development and worked in strategy consulting; also served two years as CEO of portfolio company EnobraQ.
- Where does Michael Krel work?
- Michael Krel is Partner, Industrial Biotech Strategy at Sofinnova Partners and Board director at Werewool.
- What does Michael Krel invest in?
- Michael Krel invests in AgTech, Biotech, Climate Tech, FoodTech, New Materials.
- What check size does Michael Krel write?
- Michael Krel typically writes checks of $100K – $5M.
- What boards does Michael Krel sit on?
- Michael Krel holds tracked board seats at Afyren, Comet Bio, Elicit Plant, Enginzyme, EnobraQ, Meiogenix.
- Where did Michael Krel go to school?
- Michael Krel studied at École Polytechnique (PhD, organic chemistry); ICSN (PhD, organic chemistry); ICSN (Doctor of Philosophy (Ph.D.)).
Same school
Also attended École Polytechnique161
Arthur MenschCo-founder & CEO of Mistral AIThomas WolfCo-founder & Chief Science Officer of Hugging FaceRodolphe ArdantFounder & President of SpendeskCyriac ParisotInvestor at Index VenturesPauline BoucherInvestor at DaphniMichal NatoraSenior Investment Director - Industrial IT & Robotics at Emerald Technology Ventures Ag
+ 155 more
Shared employers
Also worked at Microphyt2
Also worked at Meiogenix2
Also worked at ELICIT PLANT2
Also worked at Sofinnova Partners48
Anne HorganPartner at Cambridge Innovation CapitalLaetitia SchwabPrincipal at SR One Capital ManagementAntoine Papiernik PapiernikChairman and Managing Partner at Sofinnova PartnersGraziano SeghezziManaging Partner at Sofinnova PartnersHenrijette RichterManaging Partner at Sofinnova PartnersZhizhong YaoPartner at Sofinnova Partners
+ 42 more